Skip to main content

Senate Bill

S. 2329

119th Congress

Medicare Orthotics and Prosthetics Patient-Centered Care Act

In Committee
Introduced:Jul 17, 2025

Primary Sponsor

John W. Hickenlooper

John W. Hickenlooper

Senator

Democratic
CO

Cosponsors

1

Quick Stats

Policy Area

Health

Summary

This bill would establish a program in the FDA to support the development and approval of biological countermeasures, like vaccines, to prepare for and respond to emerging public health threats. It would provide funding for quality measures, surveillance programs, and research into platform vaccine technologies.

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

SponsorJohn W. Hickenlooper (D-CO)
Introduced7/17/2025
StatusRead twice and referred to the Committee on Finance.
ChamberSenate
Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Medicare Orthotics and Prosthetics Patient-Centered Care Act

This bill would establish a program in the FDA to support the development and approval of biological countermeasures, like vaccines, to prepare for and respond to emerging public health threats. It would provide funding for quality measures, surveillance progr

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would establish a program in the FDA to support the development and approval of biological countermeasures, like vaccines, to prepare for and respond to emerging public health threats. It would provide funding for quality measures, surveillance programs, and research into platform vaccine technologies.

Bill Number
2329
Sponsor
John W. Hickenlooper (D-CO)
Introduced
7/17/2025
Status
Read twice and referred to the Committee on Finance.
Policy Area
Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title
Medicare Orthotics and Prosthetics Patient-Centered Care Act
Bill Number
2329
Sponsor
John W. Hickenlooper (D-CO)
Status
Read twice and referred to the Committee on Finance.
Introduced
7/17/2025
Summary
This bill would establish a program in the FDA to support the development and approval of biological countermeasures, like vaccines, to prepare for and respond to emerging public health threats. It would provide funding for quality measures, surveillance programs, and research into platform vaccine

Data from Congress.gov

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.